{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:26:58Z","timestamp":1783643218507,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Cuiying Scientifc and Technological Innovation Program of Lanzhou University Second Hospital","award":["Grant numbers CY2022-MS-A09"],"award-info":[{"award-number":["Grant numbers CY2022-MS-A09"]}]},{"name":"Traditional Chinese Medicine Scientific Research Project of Gansu Province, China","award":["GZKP-2023-36"],"award-info":[{"award-number":["GZKP-2023-36"]}]},{"name":"Investigation of the Effects and Mechanisms of HTRA1 on Bladder Tumors Through Combined Non-invasive Urinary Metabolomics","award":["Grant numbers 22YF7FA090"],"award-info":[{"award-number":["Grant numbers 22YF7FA090"]}]},{"name":"Research Based on Novel Optical Fiber Biosensors for Multi-Parameter High-Sensitivity Real-Time Detection of Bladder Cancer Urinary Biomarkers","award":["Grant numbers 24YFFA049"],"award-info":[{"award-number":["Grant numbers 24YFFA049"]}]},{"name":"The Special Fund Project for Central Guiding Local Science and Technology Development","award":["Grant numbers 24ZYQA050"],"award-info":[{"award-number":["Grant numbers 24ZYQA050"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-13522-4","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T13:38:04Z","timestamp":1739281084000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Multi-omics analysis reveals the impact of YAP\/TEAD4-mediated EIF5A1 expression on mitochondrial apoptosis and bladder cancer progression"],"prefix":"10.1186","volume":"25","author":[{"given":"Kun-peng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"issue":"3","key":"13522_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"10061","key":"13522_CR2","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","volume":"388","author":"AM Kamat","year":"2016","unstructured":"Kamat AM, Hahn NM, Efstathiou JA, Lerner SP, Malmstr\u00f6m PU, Choi W, et al. Bladder cancer. Lancet. 2016;388(10061):2796\u2013810.","journal-title":"Lancet"},{"issue":"19","key":"13522_CR3","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1001\/jama.2020.17598","volume":"324","author":"AT Lenis","year":"2020","unstructured":"Lenis AT, Lec PM, Chamie K, Mshs MD. Bladder cancer: a review. JAMA. 2020;324(19):1980\u201391.","journal-title":"JAMA"},{"issue":"1","key":"13522_CR4","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.eururo.2016.02.028","volume":"70","author":"PA Humphrey","year":"2016","unstructured":"Humphrey PA, Moch H, Cubilla AL, Ulbright TM, Reuter VE. The 2016 WHO classification of tumours of the urinary system and male genital organs-part B: prostate and bladder tumours. Eur Urol. 2016;70(1):106\u201319.","journal-title":"Eur Urol"},{"issue":"3","key":"13522_CR5","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.eururo.2016.06.020","volume":"71","author":"J Alfred Witjes","year":"2017","unstructured":"Alfred Witjes J, Lebret T, Comp\u00e9rat EM, Cowan NC, De Santis M, Bruins HM, et al. Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol. 2017;71(3):462\u201375.","journal-title":"Eur Urol"},{"issue":"3","key":"13522_CR6","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.eururo.2018.09.022","volume":"75","author":"N van Dijk","year":"2019","unstructured":"van Dijk N, Funt SA, Blank CU, Powles T, Rosenberg JE, van der Heijden MS. The cancer immunogram as a framework for personalized immunotherapy in urothelial cancer. Eur Urol. 2019;75(3):435\u201344.","journal-title":"Eur Urol"},{"issue":"2","key":"13522_CR7","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00726-007-0525-0","volume":"33","author":"EC Wolff","year":"2007","unstructured":"Wolff EC, Kang KR, Kim YS, Park MH. Posttranslational synthesis of hypusine: evolutionary progression and specificity of the hypusine modification. Amino Acids. 2007;33(2):341\u201350.","journal-title":"Amino Acids"},{"issue":"3","key":"13522_CR8","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/0888-7543(95)80025-H","volume":"25","author":"A Steinkasserer","year":"1995","unstructured":"Steinkasserer A, Jones T, Sheer D, Koettnitz K, Hauber J, Bevec D. The eukaryotic cofactor for the human immunodeficiency virus type 1 (HIV-1) rev protein, eIF-5A, maps to chromosome 17p12-p13: three eIF-5A pseudogenes map to 10q23.3, 17q25, and 19q13.2. Genomics. 1995;25(3):749\u201352.","journal-title":"Genomics"},{"issue":"1","key":"13522_CR9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1006\/geno.2000.6418","volume":"71","author":"ZA Jenkins","year":"2001","unstructured":"Jenkins ZA, H\u00e5\u00e5g PG, Johansson HE. Human eIF5A2 on chromosome 3q25-q27 is a phylogenetically conserved vertebrate variant of eukaryotic translation initiation factor 5A with tissue-specific expression. Genomics. 2001;71(1):101\u20139.","journal-title":"Genomics"},{"issue":"1","key":"13522_CR10","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12964-023-01076-6","volume":"21","author":"A Mart\u00ednez-F\u00e9rriz","year":"2023","unstructured":"Mart\u00ednez-F\u00e9rriz A, Gand\u00eda C, Pardo-S\u00e1nchez JM, Fathinajafabadi A, Ferrando A, Farr\u00e0s R. Eukaryotic initiation factor 5A2 localizes to actively translating ribosomes to promote cancer cell protrusions and invasive capacity. Cell Commun Signal. 2023;21(1):54.","journal-title":"Cell Commun Signal"},{"issue":"2","key":"13522_CR11","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1158\/0008-5472.CAN-13-0474","volume":"74","author":"E M\u00e9min","year":"2014","unstructured":"M\u00e9min E, Hoque M, Jain MR, Heller DS, Li H, Cracchiolo B, et al. Blocking eIF5A modification in cervical cancer cells alters the expression of cancer-related genes and suppresses cell proliferation. Cancer Res. 2014;74(2):552\u201362.","journal-title":"Cancer Res"},{"issue":"3","key":"13522_CR12","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.3390\/ijms23031284","volume":"23","author":"M Barba-Aliaga","year":"2022","unstructured":"Barba-Aliaga M, Alepuz P. Role of eIF5A in Mitochondrial function. Int J Mol Sci. 2022;23(3):1284.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"13522_CR13","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3390\/cells8060600","volume":"8","author":"HD Huh","year":"2019","unstructured":"Huh HD, Kim DH, Jeong HS, Park HW. Regulation of TEAD transcription factors in cancer biology. Cells. 2019;8(6):600.","journal-title":"Cells"},{"issue":"1","key":"13522_CR14","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3390\/ijms17010138","volume":"17","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, Huang T, Cheng AS, Yu J, Kang W, To KF. The TEAD family and its oncogenic role in promoting tumorigenesis. Int J Mol Sci. 2016;17(1):138.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"13522_CR15","doi-asserted-by":"publisher","first-page":"109927","DOI":"10.1016\/j.isci.2024.109927","volume":"27","author":"S Hao","year":"2024","unstructured":"Hao S, Lee YJ, BenhamouGoldfajn N, Flores E, Liang J, Fuehrer H, et al. YAP condensates are highly organized hubs. iScience. 2024;27(6):109927.","journal-title":"iScience"},{"key":"13522_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mce.2017.05.033","volume":"451","author":"B Groner","year":"2017","unstructured":"Groner B, von Manstein V. Jak Stat signaling and cancer: Opportunities, benefits and side effects of targeted inhibition. Mol Cell Endocrinol. 2017;451:1\u201314.","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"13522_CR17","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1002\/ijc.28429","volume":"134","author":"M Spitzner","year":"2014","unstructured":"Spitzner M, Roesler B, Bielfeld C, Emons G, Gaedcke J, Wolff HA, et al. STAT3 inhibition sensitizes colorectal cancer to chemoradiotherapy in vitro and in vivo. Int J Cancer. 2014;134(4):997\u20131007.","journal-title":"Int J Cancer"},{"key":"13522_CR18","doi-asserted-by":"publisher","first-page":"122253","DOI":"10.1016\/j.lfs.2023.122253","volume":"335","author":"J Wang","year":"2023","unstructured":"Wang J, Li X, Chen S, Cao J, Fan X, Wang H, et al. Identification of the role of MCM6 in bladder cancer prognosis, immunotherapy response, and in vitro experimental investigation using multi-omics analysis. Life Sci. 2023;335:122253.","journal-title":"Life Sci"},{"issue":"1","key":"13522_CR19","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00432-022-04524-x","volume":"149","author":"S Wan","year":"2023","unstructured":"Wan S, Cao J, Chen S, Yang J, Wang H, Wang C, et al. Construction of noninvasive prognostic model of bladder cancer patients based on urine proteomics and screening of natural compounds. J Cancer Res Clin Oncol. 2023;149(1):281\u201396.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"13522_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13045-024-01526-9","volume":"17","author":"M Xue","year":"2024","unstructured":"Xue M, Dong L, Zhang H, Li Y, Qiu K, Zhao Z, et al. METTL16 promotes liver cancer stem cell self-renewal via controlling ribosome biogenesis and mRNA translation. J Hematol Oncol. 2024;17(1):7.","journal-title":"J Hematol Oncol"},{"issue":"19","key":"13522_CR21","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1001\/jama.2020.17601","volume":"324","author":"AT Lenis","year":"2020","unstructured":"Lenis AT, Lec PM, Chamie K. Bladder Cancer. Jama. 2020;324(19):2006.","journal-title":"Jama"},{"issue":"10","key":"13522_CR22","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41585-023-00773-8","volume":"20","author":"M Maas","year":"2023","unstructured":"Maas M, Todenh\u00f6fer T, Black PC. Urine biomarkers in bladder cancer - current status and future perspectives. Nat Rev Urol. 2023;20(10):597\u2013614.","journal-title":"Nat Rev Urol"},{"issue":"12","key":"13522_CR23","doi-asserted-by":"publisher","first-page":"922","DOI":"10.7326\/M15-0997","volume":"163","author":"R Chou","year":"2015","unstructured":"Chou R, Gore JL, Buckley D, Fu R, Gustafson K, Griffin JC, et al. Urinary biomarkers for diagnosis of bladder Cancer: a systematic review and meta-analysis. Ann Intern Med. 2015;163(12):922\u201331.","journal-title":"Ann Intern Med"},{"issue":"2","key":"13522_CR24","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1158\/2159-8290.CD-15-1321","volume":"6","author":"EE Voest","year":"2016","unstructured":"Voest EE, Bernards R. DNA-guided precision medicine for cancer: a case of irrational exuberance? Cancer Discov. 2016;6(2):130\u20132.","journal-title":"Cancer Discov"},{"issue":"2","key":"13522_CR25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nrc.2016.126","volume":"17","author":"R Dienstmann","year":"2017","unstructured":"Dienstmann R, Vermeulen L, Guinney J, Kopetz S, Tejpar S, Tabernero J. Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer. Nat Rev Cancer. 2017;17(2):79\u201392.","journal-title":"Nat Rev Cancer"},{"issue":"25","key":"13522_CR26","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1038\/onc.2014.291","volume":"34","author":"W Du","year":"2015","unstructured":"Du W, Elemento O. Cancer systems biology: embracing complexity to develop better anticancer therapeutic strategies. Oncogene. 2015;34(25):3215\u201325.","journal-title":"Oncogene"},{"key":"13522_CR27","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.biopha.2018.02.016","volume":"100","author":"J Zhang","year":"2018","unstructured":"Zhang J, Li X, Liu X, Tian F, Zeng W, Xi X, et al. EIF5A1 promotes epithelial ovarian cancer proliferation and progression. Biomed Pharmacother. 2018;100:168\u201375.","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"13522_CR28","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1158\/0008-5472.CAN-16-2594","volume":"77","author":"J Strnadel","year":"2017","unstructured":"Strnadel J, Choi S, Fujimura K, Wang H, Zhang W, Wyse M, et al. eIF5A-PEAK1 signaling regulates YAP1\/TAZ protein expression and pancreatic cancer cell growth. Cancer Res. 2017;77(8):1997\u20132007.","journal-title":"Cancer Res"},{"issue":"1","key":"13522_CR29","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13046-022-02377-3","volume":"41","author":"M Chi","year":"2022","unstructured":"Chi M, Liu J, Mei C, Shi Y, Liu N, Jiang X, et al. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K\/AKT pathway in bladder cancer. J Exp Clin Cancer Res. 2022;41(1):175.","journal-title":"J Exp Clin Cancer Res"},{"issue":"8","key":"13522_CR30","doi-asserted-by":"publisher","first-page":"3622","DOI":"10.7150\/thno.40889","volume":"10","author":"AV Pobbati","year":"2020","unstructured":"Pobbati AV, Hong W. A combat with the YAP\/TAZ-TEAD oncoproteins for cancer therapy. Theranostics. 2020;10(8):3622\u201335.","journal-title":"Theranostics"},{"issue":"5","key":"13522_CR31","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41419-018-0515-z","volume":"9","author":"M Yu","year":"2018","unstructured":"Yu M, Chen Y, Li X, Yang R, Zhang L, Huangfu L, et al. YAP1 contributes to NSCLC invasion and migration by promoting Slug transcription via the transcription co-factor TEAD. Cell Death Dis. 2018;9(5):464.","journal-title":"Cell Death Dis"},{"issue":"37","key":"13522_CR32","doi-asserted-by":"publisher","first-page":"E2441","DOI":"10.1073\/pnas.1212021109","volume":"109","author":"JM Lamar","year":"2012","unstructured":"Lamar JM, Stern P, Liu H, Schindler JW, Jiang ZG, Hynes RO. The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain. Proc Natl Acad Sci U S A. 2012;109(37):E2441-2450.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"13522_CR33","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.devcel.2008.01.006","volume":"14","author":"L Zhang","year":"2008","unstructured":"Zhang L, Ren F, Zhang Q, Chen Y, Wang B, Jiang J. The TEAD\/TEF family of transcription factor Scalloped mediates Hippo signaling in organ size control. Dev Cell. 2008;14(3):377\u201387.","journal-title":"Dev Cell"},{"issue":"10","key":"13522_CR34","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1248\/bpb.33.1666","volume":"33","author":"X Tan","year":"2010","unstructured":"Tan X, Wang DB, Lu X, Wei H, Zhu R, Zhu SS, et al. Doxorubicin induces apoptosis in H9c2 cardiomyocytes: role of overexpressed eukaryotic translation initiation factor 5A. Biol Pharm Bull. 2010;33(10):1666\u201372.","journal-title":"Biol Pharm Bull"},{"issue":"3","key":"13522_CR35","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1002\/jcp.22100","volume":"223","author":"Z Sun","year":"2010","unstructured":"Sun Z, Cheng Z, Taylor CA, McConkey BJ, Thompson JE. Apoptosis induction by eIF5A1 involves activation of the intrinsic mitochondrial pathway. J Cell Physiol. 2010;223(3):798\u2013809.","journal-title":"J Cell Physiol"},{"issue":"1","key":"13522_CR36","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.mce.2013.03.010","volume":"382","author":"SR Walker","year":"2014","unstructured":"Walker SR, Xiang M, Frank DA. Distinct roles of STAT3 and STAT5 in the pathogenesis and targeted therapy of breast cancer. Mol Cell Endocrinol. 2014;382(1):616\u201321.","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"13522_CR37","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41388-019-1009-x","volume":"39","author":"P Esteves","year":"2020","unstructured":"Esteves P, Dard L, Brillac A, Hubert C, Sarlak S, Rousseau B, et al. Nuclear control of lung cancer cells migration, invasion and bioenergetics by eukaryotic translation initiation factor 3F. Oncogene. 2020;39(3):617\u201336.","journal-title":"Oncogene"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13522-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-13522-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13522-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T21:49:46Z","timestamp":1739310586000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-13522-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,11]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13522"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-13522-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,11]]},"assertion":[{"value":"15 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval and consent to participate Ethical approval was obtained from the Institutional Review Board and Human Ethics Committee of the The Second Hospital of Lanzhou University for this study (No. 2024A-946). Informed consent was obtained from all the participants and\/or their legal guardians. In addition, the design and conduct of the animals for this study were approved (No. D2024-736).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"234"}}